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Abstract
Viral ion channels are short auxiliary membrane proteins with a length of ca. 100 amino acids. They are found in
enveloped viruses from influenza A, influenza B and influenza C (Orthomyxoviridae), and the human immunodeficiency
virus type 1 (HIV-1, Retroviridae). The channels are called M2 (influenza A), NB (influenza B), CM2 (influenza C) and Vpu
(HIV-1). Recently, in Paramecium bursaria chlorella virus (PBCV-1, Phycodnaviridae), a K selective ion channel has been
discovered. The viral channels form homo oligomers to allow an ion flux and represent miniaturised systems. Proton
conductivity of M2 is established; NB, Vpu and the potassium channel from PBC-1 conduct ions; for CM2 ion conductivity
is still under proof. This review summarises the current knowledge of these short viral membrane proteins. Their discovery is
outlined and experimental evidence for their structure and function is discussed. Studies using computational methods are
presented as well as investigations of drug^protein interactions. ß 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Ion channels are membrane spanning proteins
which allow an ion £ux across the cell membrane
by forming internal water ¢lled pores [1]. Ion chan-
nels may be formed from the assembly of short pep-
tides just long enough to span the lipid bilayer once,
such as the anti-microbial alamethicin (19 amino
acids) [2]. They can also be formed by even shorter
peptides, such as for example gramicidin (15 amino
acids) [2], which have to form dimers to fully trans-
verse the bilayer. Ion channels are also found that
consist of several subunits each built up by several
hundreds of amino acids (e.g. the nicotinic acetylcho-
line receptor has ca. 500 amino acids per subunit [3^
7]). However, in this case the assembly of subunits to
homo or hetero oligomers is an essential pre-requisite
for the creation of water ¢lled pores. The overall
nomenclature of the larger channels is related either
to the high selectivity to conduct particular ions (e.g.
K-, Na-, and Ca2-channels) or to the ligand
which induces the function (e.g. acetylcholine for nic-
otinic acetylcholine receptor, glycine for glycine re-
ceptor). Usually, all the ion channels mentioned
above conduct at least one of the physiological rele-
vant ions such as Na, K, Ca 2, Cl3 and H.
1.1. Discovery of the viral channel proteins and their
roles in the life cycle of the viruses
In the last two decades quite short auxiliary pro-
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teins with a length of ca. 100 amino acids have been
found in enveloped viruses from in£uenza A [8^10],
in£uenza B [11,12], and in£uenza C [13] (Orthomyx-
oviridae), and in the human immunode¢ciency virus
type 1 (HIV-1, Retroviridae) [14,15] (Fig. 1). Re-
cently, in chlorella plant virus PBCV-1 (Phycodnavir-
idae), a highly K selective ion channel has been
discovered that is 94 amino acids long [16] (Fig. 1).
Ion channels like nAChR or KcsA are, respectively,
ca. ¢ve times and one third bigger than the viral
channels. The viral channels therefore represent min-
iaturised channel systems.
The channel protein M2 from in£uenza A exhibits
proton conductance. According to the overall simi-
larity in the viral life cycles and the homology in
length it is suggested that the short auxiliary proteins
NB (from in£uenza B), CM2 (from in£uenza C) and
Vpu (from HIV-1), share similar roles and function
in the life cycles of their viruses.
In£uenza A viruses, like other enveloped viruses,
enter the host by attaching to the host cell’s mem-
brane. As a consequence the host incorporates this
section of the cell membrane until this section is ¢-
nally tied o¡ forming a ‘vesicle’ (endosome) with the
virion included. This type of entry is called the endo-
cytotic pathway. Once caged in the endosome the
host cell starts acidifying this compartment via ATP-
ases. The virions have to escape from this dangerous
environment. In a narrow range of pH, 5.0 to 5.5 in
the case of in£uenza A, fusion of the viral membrane
with the cell membrane of the endosome is facilitated
(see 1^4 in [17]). Membrane fusion is triggered by
conformational changes of the membrane protein
hemagglutinin, a consequence of lowering the pH
[17]. Also the release of the virus’ RNA into the
host cell is enabled by the low pH. The viral mem-
brane protein M2 is found to be responsible for
changing the pH in the interior of the virion. It is
encoded in the RNA segment 7 of in£uenza A
[10,18]. The M2 mediated change of pH is found to
be induced by the formation of a homo tetrameric
assembly forming a proton conducting channel [19^
22]. M2, transcribed in the infected cell, is also re-
sponsible for the proper structure of hemagglutinin
in the later stage of the viral life cycle [23]. Experi-
ments with amantadine, which blocks M2 channel
activity, have shown that without the function of
M2, hemagglutinin is found at the cell surface in
its low pH structure [24]. Viruses with wild type
M2 and M2 mutants resistant to amantadine do
not show hemagglutinin in its high pH conformation
at this later stage of the viral life cycle. Consequently
M2 is also e¡ective at the end of the viral life cycle
by retaining a high pH in cellular subcompartments.
For NB and CM2 the exact role in the life cycles
of the viruses is not yet identi¢ed. By analogy with
Fig. 1. Assumed topology of the putative viral ion channel proteins. Numbers indicate the amino acids which mark the beginning and
the end of the TM segment, and the total number of amino acids. The rods for Vpu indicate helical segments which are found by ex-
perimental methods.
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M2 it is suggested that NB may also have a role in
virus entry [25,26].
Vpu is expressed in the membranes of subcellular
units of infected cells and is not found in the mem-
brane envelope of the virion. It has a triple role in
the life cycle of HIV-1, for which two distinct parts
of the protein are responsible. Vpu increases virus
release by triggering a cascade of steps which ¢nally
leads to the down-regulation of CD4 protein expres-
sion on the surface of the infected cell [27,28]. CD4
protein of the host cell is the receptor to which the
virion binds. Vpu binds with its cytoplasmatic do-
main [29] to amino acids 402 and 420 of CD4 [30].
This leads to a destabilisation of CD4. Consequently
the formation of a CD4^gp160 complex is prohib-
ited. This complex would have otherwise been
‘trapped’ in the endoplasmic reticulum. gp160 is an
essential precursor of the viral coat proteins gp120
and gp41, and hence must reach the cell membrane if
secreted virions are to be functional.
Evidence for a functional role of the transmem-
brane (TM) domain of Vpu was shown by Schubert
et al. [31]. Expression of the TM domain revealed
enhanced particle release but showed no e¡ect on
CD4 degradation. Expression of the Vpu with a
‘scrambled’ TM sequence still induced CD4 degrada-
tion but was unable to enhance the release of the
virions. Deletion of several amino acids at both the
N- and C-terminal ends also leads to protein which is
not able to support particle release [32].
Recently it has been found that the down-regula-
tion of major histocompatibility complex 1 in the
infected cell is accompanied by the presence of Vpu
[33].
Sequence analysis of the double-stranded DNA of
PBCV-1 revealed a 94-codon open reading frame
that resembles the motif of the pore domain of po-
tassium channels. Experimental data about the exact
role during the viral life cycle have not yet emerged.
One might conclude that the channel retains or
modi¢es electrochemical gradients in cellular sub-
compartments or the virion itself.
1.2. Channel formation and gating of ion channels
M2 from in£uenza A has a single TM segment
which crosses the bilayer. Pores are formed by the
assembly of two homodimers linked via disul¢de
bridges [19^22]. The number of segments forming
the pore derive from M2 protein expressed in em-
bryonated eggs puri¢ed by non-reducing sodium do-
decyl sulphate^polyacrylamide gel electrophoresis
(SDS^PAGE) analysis. With this method proteins
are separated according to their molecular weight.
However, whether the number of segments is the
same in all membranes of cellular subcompartments
of the infected cell is not yet speci¢ed. This stands
also for all other viral ion channel proteins. The
structural motif of the TM segment is an K-helix.
Also, in receptors and channels (e.g. nAChR, glycine
receptor) assemblies of single helices form the pore
across the membrane [34]. They are slightly kinked
about midway through the pore and surrounded
mostly by at least two more helices in each of the
¢ve subunits.
For M2 of in£uenza A, histidine-37 has been
found to be involved in pH induced channel opening
Fig. 2. Proposed gating mechanisms for M2 from in£uenza A.
Top: mechanism I: tautomerisation or ‘£ipping histidine rings’.
Bottom: mechanism II: ‘swinging doors’. Picture adopted from
[105].
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[35]. Two possible gating mechanisms are presently
discussed in the literature: (i) a tautomerisation or
‘£ipping of the histidine rings’ (channel blocking,
mechanism I) [36], and (ii) swinging doors (gating,
mechanism II) involving electrostatic repulsion [37]
(Fig. 2). In mechanism I, one of the two nitrogens
in the histidine ring system is protonated by the low
pH and consequently the side-chain £ips around its
CK^CL bond due to the energetic state of the two
nitrogens. Additional protons on the ‘low pH’ side
attach to the ‘proton-free’ nitrogen thereby releasing
the proton of the other nitrogen which is now on the
high pH side. Mechanism II (Fig. 2) assumes that
there is an increased probability of the histidine
ring becoming doubly protonated at low pH. Con-
sequently, a positive charge emerges which leads to a
repulsion of the histidines. This repulsion forces the
histidines towards the helix^helix interface, with a
possible rotational motion of the entire helix.
For the other channel proteins exact gating mech-
anisms have not yet emerged.
1.3. Anti-viral drugs a¡ecting channel activity of M2
Until recently the only anti-viral drug available
was amantadine. Amantadine selectively interacts
with the channel protein M2 from in£uenza A in
concentrations below 1 WM [38^41]. Interaction
with all other channel proteins needs drastically high-
er concentrations. This makes amantadine applicable
for medical treatment only against in£uenza A.
There are still ongoing investigations regarding the
discovery of novel anti-viral drugs attacking the
channel proteins [42].
2. Experimental analysis
The most important achievement in protein re-
search is to provide a structural and functional mod-
el of the desired protein, and this down to an atomic
resolution (6 2 Aî ). This would create an essential
platform for further biophysical studies on the pro-
tein. It would also serve the demands for more fo-
cussed screening of potential drugs. In the case of the
viral ion channels any structural model of the full
length proteins delivered either by X-ray or nuclear
magnetic resonance (NMR) spectroscopy is still lack-
ing. This is in common with most of the other larger
ion channel proteins, except for the bacterial K-
channel [43]. Nevertheless, there have been excellent
e¡orts to deliver ‘indirect’ structural data of the
structure and function of these proteins with a vari-
ety of methods from the ¢elds of molecular biology,
electrophysiology and spectroscopy (NMR, circular
dichroism (CD), Fourier transform infrared (FTIR)
spectroscopy), including computational methods
such as molecular dynamics (MD) simulations. In
this section we will provide results and their interpre-
tation of the viral ion channel proteins. The results
of the MD simulations will be discussed in more de-
tail in Section 3.
2.1. Sequence and topology of putative ion channel
proteins: M2, NB, CM2, Vpu, Kcv
The putative viral ion channels M2, NB, CM2,
Vpu and Kcv do not show any sequence homology
(Fig. 3). M2, NB, CM2 and Vpu have in common a
sequence of ca. 22^26 amino acids with a high con-
tent of hydrophobic residues. This consequently sug-
gests that the proteins span the bilayer only once.
The loci of the TM segment is almost in the middle
of the complete sequence for M2, NB, and CM2
(Fig. 3) and close to the N-terminal (N) end for
Vpu. CM2 and Vpu are both type I membrane pro-
teins with a cleavable signal peptide (secretory signal
peptide) according to von Heijne [44]. This results in
a Nout^Cin topology (C: C-terminal end). M2, NB
and Kcv have in common a type III membrane pro-
tein topology with uncleaved N-terminal ‘start^stop’
signals which penetrates the membrane and generates
a Nout^Cin topology (according to von Heijne). For
completion: type II proteins have uncleaved ‘start^
stop’signals (starts or stops protein production) lead-
ing to a Nin^Cout topology.
So far the best characterised protein is M2 [45])
(Table 1). Its sequence of 97 amino acids is encoded
on the RNA segment 7 [46,47]. The molecular weight
of M2 is ca. 15 kDa [46,48]. It has a single phosphor-
ylation site at serine residue 64 [20,49]. SDS^PAGE
analysis following a treatment of the immunopreci-
pitate with reducing agents revealed that the mono-
mers are held together via cysteines at position 17
and 19 [23]. Another cysteine at position 50 is as-
sumed not to contribute to the linkage of the sub-
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units but is palmitoylated [50,51]. The occurrence of
bands corresponding to the molecular weight of ca.
70 kDa in the SDS^PAGE analysis of the immuno-
precipitate without using reducing agents indicates
the presence of tetramers. For M2 protein at higher
concentrations, bands corresponding to a mass of ca.
200 kDa on sucrose gradients also indicate the exis-
tence of some kind of superstructure [52,53]. How-
ever, the functional stoichiometry is found to be ho-
motetrameric [53] by using the method of
MacKinnon [54] with mixed oligomers. M2 com-
prises of an N-terminal extramembraneous part of
18^23 residues, a TM part of ca. 19 residues, and a
C-terminal cytoplasmic part of ca. 54 residues
[46,48].
NB is an integral membrane protein of 100 amino
acids in length [12] (Table 1). It contains two aspar-
agine residues (3 and 7) which are linked with carbo-
hydrates [55]. In an early stage NB exists as an un-
glycolysated protein (NB12) with a molar mass of ca.
12 kDa. NB12 can be modi¢ed with two high man-
nose carbohydrate chains into NB15 (15 kDa) and
NB18 (18 kDa). Further modi¢cation with several
lactosaminoglycan generates NBpl with a molar
weight of ca. 20^60 kDa. The ¢rst 19 amino acids
are located at the extramembraneous side, it is sug-
gested that residues 19 to 40 transverse the mem-
brane, while the remaining 60 amino acids are found
in the cytoplasm [56].
CM2 (type I) is cleaved from a precursor protein
P42 by signal peptidase when oriented in the lipid
membrane (Table 1). After cleavage it is left with a
length of 115 amino acids [57^59]. In its unglycosy-
lated form CM2 has a molecular weight of ca. 16
kDa [60]. It is post-translationally modi¢ed ¢rstly
by the addition of high-mannose carbohydrate
chains (MrV18 kDa [13]) and then further by poly-
lactosaminoglycans when still within the P42 unit
(MrV21^35 kDa [57]). The carbohydrates are added
via the ¢rst asparagine residue (Asp-26, Table 1) [58].
The ¢rst 23 residues of CM2 are extramembraneous,
the consecutive 23 residues are hydrophobic and long
enough to span the bilayer. The remaining 69 amino
acids are cytoplasmic giving its topology as Nout^Cin
[57]. Non-reducing SDS^PAGE showed that the pro-
tein is expressed as disulphide-linked dimers and tet-
ramers [57].
Vpu is a type I integral membrane protein (ca. 16
kDa [14,15]) with a hydrophobic N and a hydro-
philic C terminus [61] (Table 1). It has phosphoryla-
tion sites at serine residues 52 and 57 [27,62,63].
Chemical cross-linking experiments reveal that Vpu
exists as oligomers with approximate weights of 28,
45, 80 and 85 kDa [61]. Oligomerisation is found for
membrane-free as well as for membrane-associated
Vpu. The presence of CD4 leads to the loss of any
oligomeric assembly of Vpu. Experiments with Vpu
and Vpu hybrids provides evidence that Vpu self-as-
sembles to form homo oligomers. The exact number
of units which forms the assemblies is not known.
Kcv is 94 amino acids long. The hydropathy anal-
ysis of Kcv exhibits two hydrophobic TM segments
which are separated by a sequence of 44 amino acids
[16] (Fig. 3). This sequence contains the TxxTxGFG
motif found in K channels. The primary sequence
of Kcv di¡ers markedly from that of the other
Fig. 3. Primary sequences (notation according to SWISS-PROT data bank http://www.ebi.ac.uk/swisprot/) of the putative viral ion
channel proteins. Bold and underlined: the assumed helical TM spanning segments. For Kcv: bold: selectivity ¢lter motif.
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K channels. Phylogenetic comparison with selected
K channels (e.g. Kir, Kv, tandem K, eukaryotic
and prokaryotic K channels) suggests that Kcv be-
longs to an independent cluster. The N-terminal end
comprises a phosphorylation site at residues 9 to 12
(Table 1). The hydrophobicity pro¢le proposes TM
segments from residues 13^34 and 78^94. The C-ter-
minal end of Kcv is merged with the ¢rst TM seg-
ment which indicates a missing cytoplasmic domain.
Similar to the other viral ion channels, Kcv also is a
miniaturised channel system.
2.2. Experimental evidence for ion conductance of
viral channel proteins and synthetic TM segments
Experiments with full length M2 expressed in Xen-
opus laevis [22,64] and yeast [40] reveal channel ac-
tivity in living cells. Channel activity is found for M2
expressed in mammalian cells (CV-1) using the patch
clamp technique [65] and for M2 expressed in the
same cell line, but puri¢ed and reconstituted into
planar lipid bilayers (phosphatidyl serine:phospha-
tidyl ethanolamine, 1:1) [66]. Channel activity in
this work appears in bursts with brief currents as
high as 25^500 pS. The lowest conductance states
are recorded around 25^90 pS. More recent experi-
ments, with M2 expressed from a recombinant bacu-
lovirus in insect cells (Trichoplusia ni) puri¢ed and
reconstituted into liposomes, demonstrate proton
currents as small as 1.2 attoampere (aA) at pH V7
and 2.7^4.1 aA at pH 5.7 in a cation translocation
£uorescence assay at 18‡C [67]. Extrapolation of the
data to 37‡C would lead to conductance of 0.03 to
0.4 fS. In these experiments proton selectivity is more
than 3U106 with respect to sodium and potassium.
M2’s low single channel conductance and high pro-
ton selectivity prevents almost any perturbation of
ionic gradient whilst active. Experiments show that
histidine in the TM region is essential for channel
activity [35]. Whole cell recordings with mutants, in
Table 1
Properties of the putative viral ion channels
M2 NB CM2 Vpu Kcv[16]
Protein type III [45] III [12] III [58] I [14, 15] ^
Length (amino acids) 97 [46,47] 100 [12] 115 [57,58] 81 [14,15] 96
Phosphorylation sites Ser-64 [20,49] ^ ^ Ser-52, Ser-56
[27,62,63]
putative residues
9^12 (Tyr-Arg-
Tyr-Glu)
Glycosylation sites palmitoylated at Cys-50
[50,51]
Asp-3, Asp-7
[55].
Asp-26
[13,57,58]
^ ^
Putative channel
structure
homo-tetramer
cysteine-linked [23]
homo-pentamer
[132]
homo-tetramer
[57]
homo-pentamer
[111]
homo-tetramer
Helical structure of
solely the TM segment
reconstituted in lipid
bilayer con¢rmed by
CD (DOPC) [84],
solid state NMR [85^87].
CD [75] FTIR [90] FTIR [94] solid
state NMR [93,95]
assumed
comparable to
KcsA from
sequence
homology
Experimental tilt angle
of solely the TM
segments
NMR: 33 þ 3‡ (DMPC)
[85] 37 þ 3‡ (DMPC)
[86] FTIR: 31.6 þ 6.2‡
(DMPC) [88]
^ 14.6 þ 3.0‡
FTIR [90]
V6.5‡ (FTIR) [94],
6 30‡ (NMR) [93]
V15‡ solid state
NMR [95]
assumed
comparable with
KcsA
Structure of extramem-
braneous domains
^ ^ ^ two to three helical
domains; solution
NMR [96,97],
CD [92]
no domains
Sensitivity to
amantadine
0.1^5 WM, irreversible
for M2 protein expressed
in oocytes [22], reversible
for TM segment [21]
2 mM for NB
protein [74]
0.04^0.06 mM
TM segment,
reversible [120]
^ ^ half inhibition by
2 and 0.8 mM,
reversible
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which histidine is replaced by either glycine or lysine,
show current insensitive to low pH. Wild-type M2
drastically increases its channel conductance by 30-
fold in the same type of experiment.
Proton selectivity of the whole protein is tested
with M2 expressed in Spodoptera frugiperda Sf9 cells
and reconstituted into lipid vesicles (L-K-dimyristoyl
phosphatidylcholine (DMPC) and L-K-dimyristoyl
phosphatidyl L-serine, 0.85:0.25) using a £uorescence
assay [52]. Whole cell recordings with M2 expressed
in X. laevis are in support of proton selectivity [68].
However, the results are treated with caution. More
recent investigations on M2 transcribed in CV-1 cells
con¢rm proton conductivity [69]. Proton conduc-
tance is limited when the capacity of the bu¡er is
reduced. Whole cell measurements on oocytes with
expressed M2 in a D2O medium lead to a V50%
decrease of the membrane current. The interpretation
of this ¢nding is that the proton does not move as a
hydronium ion through the channel [69]. In a recent
investigation it is shown by the same group that M2
is also capable of conducting NH4 [70].
Experiments with a synthetic peptide construct
corresponding to the putative TM section of M2
(25 residues) reconstituted in lipid bilayer (palmito-
yl-oleoyl phosphatidylethanolamine and palmitoyl-
oleoyl phosphatidylserine, 1:1) reveal the existence
of proton conducting channels [21]. Single channel
recordings are observed with a conductance of ca.
10 pS at a pH of 2.3. Higher values are attributed
to multi-channel openings due to a higher peptide
concentration. The analysis corresponds to a tetra-
meric assembly of single TM segments. A tetrameric
assembly of the TM segment of M2 (SSDPLVVAA-
SIIGILHLILWILDRL) in dodecylphosphocholine
(DPC) induced by low pH is supported by ¢ndings
using analytical ultracentrifugation [71,72].
The relative high conductance of 10 pS compared
to the most recent data on full length M2 (0.4 fS) [69]
might be due to the fact that the segments self-as-
semble. Full length M2 strands transcribed in cells
are held together by disul¢de bridges to form a dimer
of a dimer (tetrameric assemble as a functional unit).
This linkage might allow for tightly packed channels
formed by the TM segments. The exact role of the
extramembraneous parts of M2 has therefore to be
analysed. Experiments are done with truncated M2
at residue sites 52, 62, and 82 along the cytoplasmic
end showing decreased channel activity [73]. This
study shows that the C-terminal end is essential for
stabilising the ‘open state’ of the channel. It would be
of extreme interest to know whether these trunca-
tions a¡ect the orientation of the TM segments in
respect to the membrane normal.
According to homology in topology (a 19-amino-
acid-long highly hydrophobic segment) NB is ex-
pected also to form proton or ion channels. Experi-
ments with NB transcribed in Escherichia coli and
reconstituted in a mixture of lipids (palmitoyl-oleo-
yl-phosphatidylethanolamine, palmitoyl-oleoyl-phos-
phatidylserine and palmitoyl-oleoyl-phosphatidyl-
choline, 5:3:2) reveal channel activity [74]. H
conductivity is questioned but not excluded by a se-
ries of experiments using glycine^HCl and glycine^
H2SO4. Channel activity at pH 2.5 could be attrib-
uted to Cl3 ions. At neutral pH NB forms slightly
cation selective channels (PNa/PClV9) whereas at a
pH of 2.5 the channel turns to become chloride se-
lective (PCl/PNaV4). However, conductance of pro-
tons at neutral pH is not completely ruled out by the
authors, but proton conductance is smaller than the
sodium conductance. The overall conductance level
at neutral pH is 45 pS when the protein is directly
incorporated into the lipid bilayer. Experiments with
NB pre-reconstituted into liposomes and conse-
quently added to the cis chamber of the sample hold-
er show conductance as small as 10 pS at low NB
concentration. With the same method, conductance
as high as several hundred pS are observed at higher
NB concentration due to the simultaneous opening of
several channels. These results suggest that ca. 10 pS
re£ects the lowest single conductance level observed
for NB. This level is similar to those found for the
TM segment of in£uenza A’s M2 in an arti¢cial bi-
layer [21]. The higher values also could be due to
simultaneous activity of multiple channels [21,66]. Ex-
periments with the TM segment of NB reconstituted
into a lipid bilayer (1,2-diphtanoyl-3-sn-phosphatidyl-
choline (POPC)) reveal conductance levels of ca. 20,
61, 107 and 142 pS in 0.5 M KCl bu¡er solution [75].
For CM2 no data are available to prove channel
activity of the protein.
Channel activity of Vpu is proved by reconstitu-
tion of the whole protein into planar lipid bilayers
[76]. For this study, Vpu is transcribed in E. coli and
puri¢ed. Reconstitution has been done either from a
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detergent solution or from a suspension of Vpu-con-
taining vesicles. It could be shown that Vpu channel
activity is more in preference of monovalent cations
than anions. Currents of up to 2 pA (380 mV) in a
0.5/0.05 M NaCl solution have been recorded. Re-
constitution into a lipid membrane of a synthetic
analogous to the TM region of Vpu shows channel
activity of up to 60 pS with a preference to mono-
valent cations [29]. A peptide of the same length with
a scrambled sequence does not exhibit any channel
activity.
Whole cell currents under voltage clamp condi-
tions of the complete Vpu protein in the cell mem-
brane of infected Xenopus oocyte cells is also found
with a slight preference to monovalent cations [29].
Infection of cells with cRNA encoding for Vpu and
having both phosphorylation sites mutated (Ser to
Asp) show much higher membrane currents than
cells infected with Vpu which has the intact sequence.
Voltage clamp recordings of Xenopus oocytes in-
fected with Vpu genes do not show any increase in
TM currents [77]. To summarise, Vpu is not ex-
pressed at the cell surface.
The experiments mentioned are in favour of chan-
nel activity of the full length Vpu. However, experi-
ments with any kind of blockers are still lacking and
would be the ¢nal veri¢cation of ion channel proper-
ties of Vpu [78]. Experiments with Vpu expressed in
amphibian oocytes even question direct channel ac-
tivity [77]. It is instead suggested that Vpu alters
membrane potential by destabilising host cell mem-
brane proteins. However, recent experiments with
amiloride derivatives show blocking of channel activ-
ity of a peptide analogous to the TM segment of Vpu
and full length Vpu both reconstituted in lipid mem-
branes (Ewart et al., early online publication in Eur.
Biophys. J. (2001), http://link.springer.de/link/serv-
ice/journals/00249/tocs.htm). The authors have also
shown reduced virus-like particle release from
HeLa cells in the presence of amiloride derivatives
with electron microscopy.
Kcv function is determined by expressing the pro-
tein in Xenopus oocytes [16]. Voltage clamp record-
ings show di¡erences to control oocytes. The
mRNA-injected oocytes exhibit currents up to 10
WA depending on experimental conditions. Ion selec-
tivity shows a preference for K rather than Na
ions with a ratio of PK/PNa = 9.32.
2.3. Comparison of conductance data with those from
other ion channels and channel peptides
Viral ion channel forming peptides analogous to
the TM segment of M2, NB and Vpu allow for cur-
rents for putative single channels of 10^90 pS. Also
full length NB, Vpu and Kcv operate in the same
range. This is in accord with ¢ndings on much larger
ion channels such as the receptors (nicotinic acetyl-
choline, glutamate, glycine and GABA receptors) and
voltage gated ion channels (Na-, K-, and Ca2-
channels) ([1], ch. 12, pp. 315^336). For the receptors
mainly residues such as aspartic and glutamic acids,
glutamines, serines and threonines are pore lining res-
idues. Purely TM peptides like, for example, N-toxin
from Staphylococcus aureus [79] exhibit conductances
around 70 and 100 pS at low peptide concentration
and a conductance of ca. 450 pS at higher concentra-
tions [80]. Also, synthetic peptides based on almost
the same alternating hydrophilic/hydrophobic resi-
dues lining the pore, e.g. H2N^(LSSLLSL)3^CONH2
[81], do show ion channel activity with conductance
around 70 pS in a 0.5 M KCl solution. Mellitin, an
amphiphilic peptide with largely hydrophobic resi-
dues lining the pore and some hydrophilic residues
at the C-terminal end also show conductance of ca.
110 pS in 1.8 M NaCl. In contrast, alamethicin has
purely hydrophobic pore lining residues [2]. In a pla-
nar lipid bilayer the peptide produces several conduc-
tance levels. We obtained currents of ca. 100, 310, 690
and 1180 pS (Fischer and Sansom, data not shown)
at concentrations of around 0.5 WM alamethicin
[82,83]. Small pores (6 6 segments) of alamethicin
still show quite high conductance levels. The hydro-
phobic walls of a pore wide enough to allow for a
uniform water ¢lled channel strongly enhance the dif-
fusion of the ions through the pore. However, once
hydrophilic residues line the pore the particular type
and sequence of hydrophilic amino acid within the
pore might not be of much relevance for generating
the conductance values. Instead, they seem to pro-
duce potential surfaces for ion permeation.
The most recent results on full length M2 of about
0.4 fS [69] suggest that in the case of the viral M2
channel the extramembraneous and cytoplasmic do-
mains are tightening the segments together forming
the proper environment for proton translocation. It
will be extremely important to conduct similar ex-
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periments as in [69] with the other viral channel pro-
teins with and without their non-TM domains.
2.4. Structural models of the viral channel proteins
derived from NMR, FTIR and CD spectroscopy
CD spectroscopy has given ¢rst evidence that the
TM part of M2 is helical [84] (Table 1). A synthetic
analogue corresponding to the predicted TM part of
M2 (SSDPLVVAASIIGILHLILWILDRL) is syn-
thesised and reconstituted in 1,2-dioleoyl-sn-glycero-
3-phosphocholine (DOPC). Solid state NMR spec-
troscopy is used to evaluate the orientation of the
helix in the lipid membrane [85]. Five samples, each
single site labelled with 15N on the TM isoleucines
32, 33, 35, 39 and 42, are reconstituted in DMPC
vesicles. The results showed a uniform K-helix along
the TM segment (SSAPLVVAASIIGILHLIL-
WILDRL) adopting a tilt angle of 33 þ 3‡ with re-
spect to the membrane normal. Changing the thick-
ness of the bilayer does not result in a remarkable
change in the tilt angle of M2 (37 þ 3‡ in DMPC,
33 þ 3‡ in DOPC) [86]. Re¢nement of the NMR spec-
troscopic investigations using solid state 15N polar-
isation inversion spin exchange at magic angle con-
¢rms the ¢nding of the tilt angle around 32^38‡ [87].
Site directed infrared dichroism spectra recorded on
the TM segment SSDPLVVAASIIGILHLIL-
WILDRL reconstituted in DMPC reveal a similar
tilt of 31.6 þ 6.2‡ [88]. Results from substituted cys-
teine accessibility on the TM segment (25^44) tran-
scribed in oocytes suggest that the M2 has a funnel-
like structure with its wider end towards the cyto-
plasmic side [89].
CD spectroscopy has been used to assess the sec-
ondary structure of the TM domain of NB in meth-
anol and reconstituted in POPC [75] (Table 1).
Quantitative analysis of the data for NB reconsti-
tuted in vesicles reveal ca. 65% of helix structure.
The double minimum at 208 and 222 nm usually
found for helix structure is merged to a single mini-
mum at 220 nm with a shoulder at ca. 230 nm. How-
ever, the maximum at 195 nm is typical for helix
structure regarding its position and height. Accord-
ing to the overall similarity of NB with M2 a helical
motive for crossing the lipid membrane is most
likely. Further studies have to be done to character-
ise the reason for the ‘low’ helix content.
Polarised FTIR spectroscopy with a putative TM
segment of CM2 (ENQG50YMLTLASLGL60
GIITMLYLLV70KIIIE) isotopic labelled (1-13C) at
positions Gly59/Leu66 and Gly61/Leu68 reveal a
tilt angle of the helices of (14.6 þ 3.0)‡ [90] (Table
1). The rotational pitch angle is calculated to be
(218 þ 17)‡. Assuming a pentameric assembly a glob-
al MD search protocol [91] including the data men-
tioned is run. The ‘best’ bundle structure is a left
handed coiled coil with a crossing angle of ca. 16‡.
In this structure the pore seems to be occluded by
Leu55 and Met65. Hydrogen/deuterium exchange
studies using the amide II band as reference show
that 34% of the peptide is accessible to deuterium.
This result is interpreted as a TM part of 19^20
residues which should be buried in the membrane.
The ¢rst evidence of the helical motive of the TM
segment of Vpu emerge from CD spectroscopy on
Vpu1ÿ39 in tri£uorethanol (TFE) [92]. The helical
structure of the TM domain is now also con¢rmed
by NMR [93] and FTIR [94] spectroscopy (Table 1).
NMR and FTIR spectroscopy reveal small tilt angles
of 6 30‡ (NMR) and V6.5‡ (FTIR). The discrep-
ancy between the NMR and FTIR data might be
explained by the fact that the sample for the FTIR
spectra had been dried, obtaining lipids in the gel
phase, while the solid state NMR spectroscopic
data are recorded with the lipid/peptide composition
dried on small cover glass and rehumidi¢ed to ca.
93% relative humidity. For the solid state NMR
spectroscopic data samples with single isotope la-
belled TM domains of Vpu oriented in lipid mem-
branes had been recorded. A combination of solution
and solid state NMR with uniformly 15N labelled full
length Vpu and fragments such as Vpu2ÿ51 and
Vpu28ÿ81 reveal tilt angles for the TM segment of
V15‡ and orientation of Vpu28ÿ81 parallel to the
membrane surface [95]. Full length Vpu and the in-
dividual fragments are expressed in E. coli and then
reconstituted in micelles or lipid bilayers in this
study.
In 1995, the ¢rst attempt was made to elucidate
the structure of the cytoplasmic domain [92]. Nine
short segments consisting of 15 amino acids corre-
sponding to a sequence of the cytoplasmic domain
(residues 28 to 81) were synthesised by solid phase
peptide synthesis. Starting with a segment Vpu28ÿ42
this window of 15 amino acids was ‘moved’ towards
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the C terminus resulting ¢nally in the peptide
Vpu67ÿ81. The analysis of the CD spectra of each
of these segments recorded in a mixture of TFE
and water proposed substantial helicity for each seg-
ment. In combination with 1H NMR spectra it was
suggested that Vpu adopts a helical structure from
residue 42 to 50 and from residue 57 to 69. These
helices and their position have been re¢ned in later
studies by the same authors suggesting a helix^£exi-
ble-helix^turn motive with helices at positions Lys-37
to Asp-51 and Glu-57 to His-72 [96]. Another group
recorded NMR spectra of a peptide corresponding to
the complete cytoplasmic domain in aqueous solu-
tion with high salt concentration [97]. Helices are
suggested to extend from positions Asp-40 to Ala-
50 and Asp-60 to Val-68. A shorter helix from Pro-
75 to Asp-79 was also found.
Solid state NMR experiments with single isotope
labelled Vpu ([15N-Leu45]Vpu27ÿ57) with and without
phosphorylation at the two serines 52 and 56 do not
show any major impact of phosphorylation on helix
orientation of this segment [98]. However, signal dis-
tribution for the phosphorylated peptide accounts
for a broad range of di¡erent orientations. This
can be best explained by a weakened association of
the segment with the membrane. Segments with Vpu
close to its C-terminal end ([15N-Ala62]Vpu51ÿ81)
show large 15N chemical shift anisotropy. This indi-
cates that there is no speci¢c alignment with the
membrane. Synchrotron X-ray re£ectivity data sug-
gest similar orientation of parts of Vpu on a mem-
brane surface [99]. Also, parts of the protein are
aligned parallel to the membrane normal. Low sur-
face pressure seems to be in favour of the TM part of
the protein being within the lipid environment where-
as the cytoplasmic domain seems to have no contact
with the membrane. At higher surface pressures part
of the cytoplasmic tail orients parallel to the mem-
brane surface.
Experimental evidence for the teepee-like structure
of Kcv has not yet emerged.
3. Computational analysis: channel structure and
possible gating mechanisms
The ‘indirect’ structural data discussed in Section 2
allow us to construct a relatively good ‘low resolu-
tion’ model of particular viral ion channels. How-
ever, with the need of a ‘high (atomic) resolution’
structure, computational methods such as MD sim-
ulations serve as a link between the two models until
the latter is available from experiment. Computation-
al methods will not only allow the visualisation of
the results on an atomic scale, but will also let ¢rst
gentle questions on the role of particular side-chains;
the mechanics of the protein, and drug^protein inter-
actions based on the laws of biophysics to be ad-
dressed. Once we are in possession of atomic struc-
tures from experiments MD simulations will further
provide a link from structure to function. The fol-
lowing paragraphs provide an overview of the prog-
ress of investigations using computational derived
models, and what is needed for the future.
3.1. MD simulations on M2
Simulations with a homotetrameric ensemble of
the TM region of M2 (Ac-LVIAASIIGILHFIL-
WIL-NH2) in a hydrophobic slab of a low dielectri-
cum is conducted in the presence of water molecules
[37,100] (Table 2). This region has been found to
form a core helical region despite the overall length
of the single TM segment [101]. The four helical TM
segments are designed to form a left handed super
coiled bundle with a tilt angle of 5‡. This alignment
allows for key residues such as F38, A30, S31, G34,
H37, F38, and W41 to be within the pore lumen. The
position of these residues is now proved by experi-
mental ¢ndings [89]. In this study [89] M2 mutants
have been generated in which the residues mentioned
have been replaced by cysteines. The accessibility of
these cysteine mutants to sulfhydryl-speci¢c reagents
(substituted-cysteine accessibility method) was tested
using whole cell current measurements. For this oo-
cytes were used as expression system for the M2
mutants. H37 is assumed to act as a gate due to its
pKa of 6.1. As a possible gating mechanism it is
proposed that protonation of the histidines induce
a kind of ring £ipping (model I) [102] (Fig. 2).
With the pyrrole rings aligned perpendicular to the
membrane surface protonation on one of the nitro-
gen atoms induce a rotational motion thereby mov-
ing the proton to the high pH side. Models with all
four histidines protonated and unprotonated are
constructed to represent the open and closed state,
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respectively (model II) [100]. All models increase
their super coiling during a simulation of 1 ns result-
ing in tilt angles of 20^25‡. This allows for a stronger
crossing of the helices of up to 35‡. Interestingly, the
closed state (all four histidines unprotonated) inter-
rupts the continuous water column found for the
open state (all histidines protonated). In the latter
case the histidines orient towards the helix^helix in-
terface. In a more recent study with a similar model a
water-¢lled ‘cavity’ within the bundle has been re-
vealed [103]. Three water molecules do not appear
to exchange with the surrounding waters during the
entire duration of the simulation. Simulations (4 ns)
of four parallel orientated TM segments
(SSDPLVVAASIIGILHLILWILDRL) in the bilayer
mimetic octane tend to form similar left handed
super coiled structures (tilt angle at the end of the
simulations 27 þ 5‡) [104] as found in the simulations
mentioned [103]. For the ‘closed’ state (histidines un-
protonated) water molecules only gradually enter the
pore half way through the simulation [104]. The pro-
tonation of two histidines forces the histidines to give
way to a uniform water column. Simulations with
tetrameric bundles of the TM segment of M2 in a
bilayer system with two and four of the histidines
protonated result in a similar e¡ect on the bundles
[105]. Simulations with a tetrameric bundle of the
putative TM region of M2 in an octane slab, having
one protonated histidine, also show an opening of
the bundle and the formation of a water column
through the pore [106]. Simulations with a longer
TM segment suggest that residues S23 and D24
may also play a role in the gating mechanism of
the channel [107] [101]. Investigations of the ionisa-
Table 2
Simulations performed on the viral ion channel proteins
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tion states of the aspartic residues by calculating
their pKa values suggested that only one residue is
unprotonated. Also, these bundles seem to remain
stable during the simulation in a fully hydrated bi-
layer (POPC) and allow for a water ¢lled pocket at
the C-terminal end of the pore. Simulations of bun-
dles with TM segments of di¡erent length (consisting
of 18 or 22 amino acids) suggest that the bundle with
the shorter segment retains the initial tilt angle better
than bundles with longer segments. The e¡ect is at-
tributed to the compensation for hydrophobic mis-
match of the bundles with longer segments because
of the thickness of the bilayer.
The general feasibility of generating models of TM
helical bundles by the assumptions mentioned above
is demonstrated in a comparative study of those bun-
dles and bundles built upon experimental constraints
[108].
3.2. MD simulation on NB and CM2
For NB the exact number of segments forming a
channel is not yet known. Experiments with gels
under non-reducing conditions indicate the forma-
tion of disulphide-linked dimers and also oligomers
[56]. Similarity in the length of NB with M2 and the
almost identical life cycles of these viruses suggest
that the TM region of NB also adopts a helical struc-
ture. Bundles of four, ¢ve and six segments accord-
ing to the putative TM section of NB are generated.
They are placed in a hydrophobic slab with a low
dielectricum and restraint MD simulations are ap-
plied [109] (Table 2). The super coiling seems to be
reduced at the end of the simulation (100 ps). Esti-
mated conductance based on ohmic calculation of an
irregular ‘tube’ of electrolyte solution of the same
dimension as the interior of the channel including
an empirical correction for the lowered mobility of
waters in restricted geometries are in agreement with
experimental data. Bundles of ¢ve segments seem to
be the most appropriate model for the NB channel
architecture. The stability of the isolated helical TM
strands in a fully hydrated lipid bilayer (POPC) is
tested with three single TM segments of di¡erent
lengths (20, 28 and 36 amino acids in length) repre-
senting the most likely TM region [110]. Each of the
single strands are placed individually into a lipid bi-
layer (POPC) and the whole system hydrated. Simu-
lations for 1 ns reveal fairly stable segments. Seg-
ments of 28 amino acids in length are chosen to
form bundles of di¡erent size (four, ¢ve and six seg-
ments) (Fig. 4) [75]. These bundles are also placed in
a lipid bilayer and the simulation run for 1 ns. The
segments are orientated in such a way that all the
hydrophilic residues (serines and threonines) are fac-
ing the pore. Calculations of the conductance of a
0.5 M KCl solution based on the pore diameters of
the bundles after 1 ns reveal a minimum value of 20
pS for the bundle of four segments. Agreement with
the lowest values found in the experiments [75] indi-
cate a bundle as small as the M2 channel from in-
£uenza A. The bundles were constructed with no
Fig. 4. Bundle of four (left), ¢ve (middle) and six segments (right) of NB after 1 ns simulation in a fully hydrated lipid bilayer. To
see inside the bundle one segment of the bundle-4 is omitted for clarity. Two segments in each bundle-5 and bundle-6 are removed.
Serines and threonines are shown in stick modus (dark grey). Not shown are lipid bilayer and the water molecules present in the sim-
ulation. N- and C-terminal ends are indicated. The dashed line indicates the boundaries of the lipid bilayer. Graphs were generated
using MOLSCRIPT.
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initial tilt angle. At the end of the simulation there is
a trend of a decreasing tilt angle with increasing
numbers of segments. The position of the side-chain
remain stable during the simulation.
For CM2 similar calculations with single helical
TM segments are undertaken [110] (Table 2). Similar
to NB and Vpu the strands remain their helicity. The
subsequent assembly of the strand with 28 amino
acids give rise to stable bundles as well. However,
residues such as lysine and glutamic acid form salt
bridges at the C-terminal of the pores of the CM2
bundles (Fischer and Sansom, unpublished results).
3.3. MD simulations on Vpu and Kcv
Vpu: two approaches are undertaken to perform
modelling and simulation studies on the TM segment
of Vpu [111,112] (Table 2). In an investigation of
assembled TM domains of Vpu (IVAIVA10
LVVAIIIAIV20VWSIVII) by Sansom et al. [111]
bundles consisting of four, ¢ve and six helices per
bundle are generated. In these bundles the serines
are placed towards the interior of the bundle. Simu-
lations are performed with the bundles placed in an
arti¢cial bilayer represented by a hydrophobic slab
and with restraints regarding the helicity of the bun-
dles and their assembly. Water molecules are also
constrained to remain within the mouth of the bun-
dle during the simulation. Potential energy pro¢les
for ion/channel interactions support the experimental
¢nding of a weak cation selectivity over anion selec-
tivity. Calculation of the conductance and compari-
son with experimental results suggest that the most
plausible bundle structure would be a pentameric
assembly.
In a second approach, simulations (1 ns) of two
hydrated pentameric bundles embedded in octane, a
bilayer mimic, have been performed without any re-
straints on the peptide helices [112]. The same TM
sequence is used as in Grice et al. [111]. One of the
model is built according to the model of Grice et al.
[111] in which all serines are facing the lumen of the
pore. A second model is built placing all the trypto-
phans explicitly so that they face the pore. Both
structural models have in common (i) an orientation
of the tryptophans towards the helix/helix and helix/
lipid interface, and (ii) the disappearance of a con-
tinuous water column within the bundle. All bundles
adopt a conical shape with a water-¢lled pocket to-
wards the C-terminal end. The data are interpreted
in terms of a non-ion-conducting pore. An average
tilt angle of the segments with respect to the octane
normal was calculated to be 4.2‡ [113].
FTIR spectroscopic data in combination with
globular MD support a pentameric TM bundle
(MQPIQIAIVA10LVVAIIIAVV20WSIVIIEYRK)
with all tryptophans pointing into the pore [114].
This bundle structure is interpreted as a potential
‘closed’ structure of the channel. In contrast, models
with the tryptophans at the helix^lipid headgroup
interface might represent an ‘open’ structure [111].
Simulations in a fully hydrated lipid bilayer (POPC)
Fig. 5. Bundle of four (left), ¢ve (middle) and six segments (right) of Vpu after 1 ns simulation. Description as in Fig. 4. Serines are
shown in stick modus (dark grey).
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were undertaken with (i) one model from Arkin et al.
[114], (ii) an equivalent model built in silico using a
combined Xplor and SA/MD approach [115,116],
and (iii) model with serines facing the pore [116].
For models (i) and (iii) tryptophans in all segments
move towards the helix/helix interface during the
simulations. In the case of model (ii) all tryptophans
remain in the pore. In conclusion, it is possible that
gating is via a rotational-like motion of the seg-
ments, rather than the incorporation or omission
of another segment to or from the existing circular
assembly. Such a ‘screw-like’ motion would block
the channel by exposing hydrophobic residues to
the pore and creating a dielectric barrier which can-
not be passed by ions. A similar barrier is proposed
to exist in the nicotinic acetylcholine receptor [117].
Simulations were also performed on extended
TM segments (28 amino acids) forming bundles of
four, ¢ve and six segments embedded in a hydrated
lipid bilayer (Fig. 5) generated as mentioned for
NB. Focussing on particular side-chains such as ar-
ginines indicate that these residues point into the
pore, literally occluding the pore (Cordes, Sansom,
Fischer, to be published). Since Vpu shows channel
activity, the model might re£ect only a ‘snapshot’ of
possible orientations of these residues in vivo. Thus,
inclusion of the extramembraneous parts of Vpu in
the simulation studies are essential. This makes the
need of a high-resolution structure of complete Vpu
and, of course, the other viral channel proteins ob-
vious.
For Kcv no simulations have yet been performed.
3.4. Expectations for the future
We are still missing detailed structural data of the
full length membrane proteins. All simulation and
most of the spectroscopic analysis has up to now
mostly been done with peptides analogous to the
TM segments. It is probable that the extramembra-
neous and cytoplasmic segments a¡ect tilt angles of
the TM segments and therefore the orientation of
essential side-chains (e.g. histidines in M2). Simula-
tion on larger systems is already possible. Thus, the
next step in simulations should be to include the non-
TM parts as best as possible. Simulations on bundles
of these larger single segments will of course be of
further interest.
4. Channel^drug interaction
Channel activity of M2 is inhibited by amantadine
(1-aminoadamantane hydrochloride) [118] and ri-
mantadine (K-methyl-1-adamantane methylamine hy-
drochloride) (for reviews see [119^122]). Above 0.1
mM amantadine e¡ects the membrane fusion activity
of haemagglutinin during endocytosis ([38] and refer-
ences therein). However, this e¡ect is not restricted
to amantadine but also can also be found with other
compounds such as amines. Also the development of
other enveloped viruses such as in£uenza B and some
RNA viruses can be inhibited in this concentration
range. Concentrations between 0.1 and 5 WM, how-
ever, exhibit strain-speci¢c inhibition during the en-
try of the virus and its assembly in the later part of
the life cycle. Amantadine-resistant strains from Sin-
gapore, Rostock, and Weybridge have mutations at
positions 27, 30, 31 and 34. They are located in the
putative TM region of the channel protein M2 [38].
Single channel recordings with a synthetic analogue
of the TM region of M2 show that exactly this seg-
ment is responsible for channel blocking with aman-
tadine in a concentration of 20 WM [21]. The e⁄-
ciency of M2 inhibition by ca. 100 WM follows the
sequence of the virus strands UdornsWeybridg-
esRostock [22]. The Weybridge strain is character-
ised by several mutations from which two are within
the TM region of M2. To test whether the TM re-
gion is responsible for the sequence of e⁄ciency mu-
tations of the Rostock strand at I-27-V and L-38-F
are produced. Analysis with either a I-27-V or a L-
38-F single residue mutant reveal that the former
mutation can more easily be blocked by amantadine.
The amantadine block of M2 protein expressed in
oocytes of X. laevis is irreversible [22]. If M2 protein
is expressed (in either S. frugiperda or in in£uenza A
infected CV-1 cells), puri¢ed, and reconstituted into
lipid bilayers, recordings in the presence of amanta-
dine show reduced probability of opening [66]. Also
M2 channel is less often in its most probable con-
ductance state. Amantadine blocks M2 in its tetra-
meric form [72]. Investigations of the TM segment of
M2 in DPC in the presence of amantadine by ana-
lytical ultracentrifugation indicate that the peptide
tends to be in the tetrameric state. The results are
interpreted in the terms of amantadine competing
with the protons for binding to deprotonated histi-
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dines in the tetramer. Whole cell current measure-
ments of M2 expressed in oocytes of X. laevis in
the presence of Cu(II) inhibit channel activity [123].
Two di¡erent binding sites for Cu(II) are found, one
site with low binding speci¢city and one site with
high a⁄nity. The type of interaction and the induced
current behaviour for Cu(II) binding to the latter site
seems to be similar to the inhibition of amantadine.
Since mutations of His-37 by alanine or glycine elim-
inates binding at the high a⁄nity site, these results
have been taken as a further support for the location
of the amantadine binding site within the TM region
of M2.
NB channel activity is also a¡ected by the presence
of amantadine. Bilayer experiments of NB tran-
scribed in E. coli and reconstituted into the lipid
bilayer (palmitoyl-oleoyl-phosphatidylethanolamine,
palmitoyl-oleoyl-phosphatidylserine and palmitoyl-
oleoyl-phosphatidylcholine, 5:3:2) indicate lower
and less frequent currents in the presence of the
anti-viral drug [74]. However, the concentration of
amantadine necessary for these ¢ndings is several
orders of magnitude higher (ca. 2 mM) than those
e¡ecting M2 (0.1^5 WM). Experiments with solely the
TM segment of NB reconstituted in POPC show
similar current behaviour at the lower drug concen-
tration of around 0.04^0.06 mM [124].
Whether amantadine a¡ects channel activity by
simply blocking the pore or via allosteric coupling
is not yet fully understood. Experiments support
the latter type of blocking [66]: (i) inhibition is
more favoured in the open state, (ii) there is a re-
duced mean current in the presence of amantadine,
and (iii) there is no recti¢cation in the presence of
charged amantadine. Neutron di¡raction experi-
ments with amantadine in the presence of lipids
show that amantadine penetrates into the lipid mem-
brane and interacts with M2 at speci¢c sites [125].
Amantadine is found around 5 Aî from the centre of
the bilayer. This suggests an interaction site with
Val-27 and Ser-31. A steric block within the channel
is suggested. Computational methods reveal a mini-
mum in the energy pro¢le along the pore axis for
amantadine in this region [100].
Kcv is blocked with a three orders of magnitude
higher amount of amantadine than M2 [16]. The in-
hibition is voltage independent and can be reversed
within minutes of amantadine removal. These results
suggest that the inhibition of Kcv induced by aman-
tadine is di¡erent from the inhibition of M2.
A spirene-containing compound BL-1743 (2-[3-
azaspiro (5,5)undecanol]-2-imidazoline) has been
also found to a¡ect virus growth [39] by blocking
channel activity of M2 [40]. A virus strand with a
mutation I-35 to T is by far more resistant (s 70-
fold) to BL-1743 than to amantadine. This suggests
that the drug^protein interaction is di¡erent for these
two drugs.
Several derivatives of amantadine have been syn-
thesised [42] and tested for anti-viral activity using
protocols which are described by De Clerq et al.
[126^128]. Spiro piperidine- and spiro morpholine-
amantadine with a six-membered heterocyclic ring
and molecules with a rimantadine body and pyrroli-
dine rest show high potency against in£uenza A if
the valency of the nitrogens is satis¢ed with hydro-
gen atoms. The same molecules are active against
in£uenza B as well, albeit in higher concentrations.
If the nitrogen is connected with aliphatic rests, po-
tency against HIV-1 rises, but not yet su⁄cient to
give a major breakthrough.
5. Conclusion and outlook
In recent years there is a relatively clear picture
evolving regarding the structure and function of, in
particular, two channels: M2 from in£uenza A and
Vpu from HIV-1. It is accepted that M2 is a proton
conducting disulphide-linked homotetrameric proton
channel. The protein spans the lipid bilayer via an K-
helix. Its conductance can be selectively blocked by
amantadine which forms the basis of its anti-viral
use. Vpu seems most likely to form a homopenta-
meric assembly with helical TM segments. Ion con-
ductance is suggestive and preferentially of cations.
Whether channel activity is the in vivo source of its
functioning is, however, still being debated. Also no
channel blocking of amantadine is observed which
might question the formation of ‘real’ channels.
Vpu is the only channel for which we have sugges-
tions for the structure of the extramembraneous part.
Channel activity for NB protein has been found as
well as experimental evidence that the TM segment
forms an K-helix. Ion conductance and ion prefer-
ence is dependent upon the experimental conditions.
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The number of proteins needed to assemble to form
a proper channel can only be speculated; it might
range from four to six units. Less is known about
CM2. FTIR spectroscopic data suggests a helical
motive for the TM spanning part, however, channel
activity still has not been demonstrated either in cells
or with protein or peptide reconstituted into lipid
bilayers. Kcv’s structure is suggested according to
the homology of its sequence to the TM part of
the K-channel proteins.
Despite all experimental evidence for ion channel
activity of NB protein, Kcv and Vpu protein, our
knowledge about channel activity might still be a
consequence of the expression of these membrane
proteins in particular cells. Unless a selective blocker
is found for these proteins and tested in cell systems,
the term ‘ion channel’ has still to be used with some
caution (see [77] for a thorough assessment of this
topic). However, the most recent results on Vpu re-
garding selective blocking of channel activity are in
favour of Vpu as an ion channel forming protein
(Ewart et al., early online publication in Eur. Bio-
phys. J. (2001), http://link.springer.de/link/service/
journals/00249/tocs.htm).
For M2 it is found that the protonation state of the
histidines is essential for gating. Protonation of the
histidines would force them either to rotate or to
move apart from each other caused by electrostatic
repulsion. In the latter case this would go in concert
with a rotational like motion of the helices. For Vpu a
similar gating mechanism looks likely. Twist like rota-
tional motions of parts of the TM segments has been
suggested for more complex ion channels like the
nAChR [117]. For the Na-channels a ‘screw-like’
motion is predicted for the TM voltage sensor (S4)
of the channel upon a high transmembrane potential
[129^131]. The viral ion channels seem to use similar
mechanisms for gating albeit their minimalist design.
We are still at the beginning of understanding the
viral ion channels on a structural level. Detailed high
resolution structural data are urgently required to
allow the application of computational based meth-
ods for the investigation of drug^protein interaction.
In parallel more information about the role of these
membrane proteins in the life cycle of the virus is
essential. The viral membrane proteins are an ex-
tremely interesting target to study membrane protein
activity on a minimalist design. This might also stim-
ulate the design of novel synthetic channel forming
compounds.
In addition, the discovery of the Kcv channel in
plant viruses also gives us a glimpse of the kind of
viral ion channel we still might ¢nd in other viral
genomes.
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